Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe

Koletzko, S.; Richy, F.; Bontems, P.; Crone, J.; Kalach, N.; Moneiro, M. L.; Gottrand, F.; Celinska-Cedro, D.; Roma-Giannikou, E.; Orderda, G.; Kolacek, S.; Urruzono, P.; Martínez-Gómez, M. J.; Casswall, T.; Ashorn, M.; Bodanszky, H.; Mégraud, F.
December 2006
Gut;Dec2006, Vol. 55 Issue 12, p1711
Academic Journal
Aim: To prospectively assess the antibacterial resistance rate in Helicobacter pylori strains obtained from symptomatic children in Europe. Methods: During a 4-year period, 17 paediatric centres from 14 European countries reported prospectively on patients infected with H pylori, for whom antibiotic susceptibility was tested. Results: A total of 1233 patients were reported from Northern (3%), Western (70%), Eastern (9%) and Southern Europe (18%); 41% originated from outside Europe as indicated by mother's birth-country; 13% were <6 years of age, 43% 6-11 years of age and 44% >11 years of age. Testing was carried out before the first treatment (group A, n = 1037), and after treatment failure (group B, n = 196). Overall resistance to clarithromycin was detected in 24% (mean, A: 20%, B: 42%). The primary clarithromycin resistance rate was higher in boys (odds ratio (OR) 1.58; 1.12 to 2.24, p = 0.01), in children <6 years compared with >12 years (OR 1.82, 1.10 to 3.03, p = 0.020) and in patients living in Southern Europe compared with those living in Northern Europe (OR 2.25; 1.52 to 3.30, p<0.001). Overall resistance rate to metronidazole was 25% (A: 23%, B: 35%) and higher in children born outside Europe (A: adjusted. OR 2.42, 95% CI: 1.61 to 3.66, p<0.001). Resistance to both antibiotics occurred in 6.9% (A: 5.3%, B: 15.3%). Resistance to amoxicillin was exceptional (0.6%). Children with peptic ulcer disease (80/1180, 6.8%) were older than patients without ulcer (p=0.001). Conclusion: The primary resistance rate of H pylori strains obtained from unselected children in Europe is high. The use of antibiotics for other indications seems to be the major risk factor for development of primary resistance.


Related Articles

  • ...but H pylori resistance to antibiotics in Spain has risen over the past 5 years.  // Modern Medicine;Dec96, Vol. 64 Issue 12, p15 

    Cites a study conducted by physician Teresa Alarcon and colleagues concerning the resistance to the antibiotic clarithromycin by Helicobacter pylori clinical isolates in Spain in 1995. Increase in use of new macrolides in children for other infections; Percentage of rise in antibiotic...

  • Costs of Diagnosis and Treatment of Helicobacter pylori Infection: When Does Choosing the Treatment Regimen Based on Susceptibility Testing Become Cost Effective? Breuer, Thomas; Graham, David Y. // American Journal of Gastroenterology;Mar1999, Vol. 94 Issue 3, p725 

    OBJECTIVE: Antibiotic-resistant Helicobacter pylori (H. pylori) strains are becoming increasingly prevalent. Currently, most physicians treat H. pylori infections without relying on antimicrobial susceptibility testing to choose the best regimen. This study was conducted to...

  • Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. Cuadrado-Lavín, Antonio; Salcines-Caviedes, J. Ramón; Carrascosa, Miguel F.; Mellado, Purificación; Monteagudo, Idoia; Llorca, Javier; Cobo, Marta; Campos, M. Rosario; Ayestarán, Blanca; Fernández-Pousa, Antonio; González-Colominas, Elena // Journal of Antimicrobial Chemotherapy (JAC);Jan2012, Vol. 67 Issue 1, p170 

    Background Antibiotic resistance is directly related to the loss of efficacy of currently accepted Helicobacter pylori therapies. Knowledge of the antibiotic susceptibility in a local area can contribute to the design of specific ‘à la carte’ treatments. The aim of this study was...

  • Epidemiology and Pattern of Antibiotic Resistance in Helicobacter pylori: Scenario from Saudi Arabia. Rizwan, Mohammed; Fatima, Nuzhath; Alvi, Ayesha // Saudi Journal of Gastroenterology;Jul/Aug2014, Vol. 20 Issue 4, p212 

    Helicobacter pylori is recognized as a major cause of gastritis, peptic ulcer, gastric cancer, and mucosa‑associated lymphoma. Infection with this gram‑negative microaerophile has been treated using combination of antibiotics and proton pump inhibitors for different...

  • H. pylori resistance rates increasing due to antibiotic therapy.  // Infectious Disease News;May2014, Vol. 27 Issue 5, p25 

    The article reports that standard triple therapy and sequential therapy has increased the antibiotic resistance of Helicobacter pylori, according to data published in the "American Journal of Gastroenterology."

  • Enrichment of anti-ulcer activity of monoammonium glycerrhizin and Aloe vera gel powder through a novel drug delivery system. Ranade, Arati N.; Ranpise, Nisharani S.; Ramesh, Chakrapani // Asian Journal of Pharmaceutics (Medknow Publications & Media Pvt;Oct-Dec2014, Vol. 8 Issue 4, p222 

    Usual treatment for Helicobacter pylori-induced peptic ulcer includes a 14-day "triple therapy" of two antibiotics and a proton pump inhibitor . However, the current therapy has side-effects like stomach upset, non-compliance, incomplete absorption of drug and antibiotic resistance. To overcome...

  • NICE dyspepsia advice to E fuel microbial resistance. Pedder, Cato // Pulse;5/21/2005, Vol. 65 Issue 20, p8 

    Reports that a NICE guidance on treating Helicobacter pylori infection in patients with dyspepsia could lead to a surge in antibiotic resistance, according to senior government advisers in Great Britain. Discovery by a study that 59 percent of isolates were resistant to metronidazole; Advice...

  • A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility. Perna, Federico; Vaira, Dino // Journal of Clinical Pathology;Jul2010, Vol. 63 Issue 7, p16 

    Background Clarithromycin (CH) and metronidazole (MZ) are routinely used in Helicobacter pylori treatment regimes. Recently, treatment with these antibiotics has been reported to fail in >30% of patients due to increasing resistance. The common chemosusceptibility methods are cumbersome and take...

  • Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. Ribeiro, Marcelo L.; Vitiello, Lea; Miranda, Maira C. B.; Benvengo, H. B.; Godoy, Anita P. O.; Mendonca, Sergio; Pedrazzoli Jr, José // Annals of Clinical Microbiology & Antimicrobials;2003, Vol. 2, p1 

    Background: Resistance of Helicobacter pylori to clarithromycin has been associated with A2142G and A2143G point mutations in the 23S rRNA gene. Thus, the purpose of the present study was to determine the prevalence of each mutation in 52 clarithromycin-resistant H. pylori strains and to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics